{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:35:56Z","timestamp":1790800556775,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.03.079","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T23:36:39Z","timestamp":1459294599000},"page":"2988-2991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Advancing a vaccine to prevent human schistosomiasis"],"prefix":"10.1016","volume":"34","author":[{"given":"Maureen","family":"Merrifield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coreen M.","family":"Beaumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Strych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.079_bib0215","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0220","series-title":"Schistosomiasis \u2013 PCT database","author":"WHO","year":"2015"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0225","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(15)00084-5","article-title":"Schistosomiasis reaches Europe","volume":"15","author":"Boissier","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0240","doi-asserted-by":"crossref","first-page":"e0003504","DOI":"10.1371\/journal.pntd.0003504","article-title":"It's time to dispel the myth of asymptomatic schistosomiasis","volume":"9","author":"King","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0956462414523743","article-title":"Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies","volume":"25","author":"Kjetland","year":"2014","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0250","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.1221396110","article-title":"Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa","volume":"110","author":"Ndeffo Mbah","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0255","doi-asserted-by":"crossref","first-page":"e3234","DOI":"10.1371\/journal.pntd.0003234","article-title":"Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa","volume":"8","author":"Ndeffo Mbah","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0260","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pt.2014.05.004","article-title":"Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer","volume":"30","author":"Honeycutt","year":"2014","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0265","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study Collaborators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0270","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1371\/journal.pntd.0002562","article-title":"Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts","volume":"7","author":"Keenan","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: praziquantel forever","volume":"195","author":"Cioli","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0285","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0290","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1080\/21645515.2015.1059981","article-title":"Still hope for schistosomiasis vaccine","volume":"11","author":"Ricciardi","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0295","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0065-308X(08)60048-2","article-title":"The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine","volume":"39","author":"Coulson","year":"1997","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/IAI.65.1.42-48.1997","article-title":"Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes","volume":"65","author":"Coulson","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0305","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1128\/IAI.72.9.5526-5529.2004","article-title":"Parameters of the attenuated schistosome vaccine evaluated in the olive baboon","volume":"72","author":"Kariuki","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2478(98)00134-5","article-title":"Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice","volume":"65","author":"Wilson","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0315","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.4049\/jimmunol.156.12.4739","article-title":"Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant","volume":"156","author":"Mountford","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0320","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.4049\/jimmunol.154.9.4701","article-title":"IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia","volume":"154","author":"Wynn","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0325","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fimmu.2015.00213","article-title":"Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates","volume":"6","author":"Pearson","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0330","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijpara.2015.03.004","article-title":"A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets","volume":"45","author":"Sotillo","year":"2015","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0335","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4939-1438-8_13","article-title":"Protein microarrays for parasite antigen discovery","volume":"1201","author":"Driguez","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-3024.2003.00603.x","article-title":"Differential production in vitro of antigen specific IgG1, IgG3 and IgA: a study in Schistosoma haematobium infected individuals","volume":"25","author":"Beniguel","year":"2003","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0345","doi-asserted-by":"crossref","first-page":"e1704","DOI":"10.1371\/journal.pntd.0001704","article-title":"Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis","volume":"6","author":"Riveau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0350","unstructured":"ClinicalTrials.gov. Efficacy of Vaccine Sh28GST in Association With Praziquantel (PZQ) for Prevention of Clinical Recurrences of Schistosoma Haematobium Pathology (Bilhvax)."},{"key":"10.1016\/j.vaccine.2016.03.079_bib0355","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1430","article-title":"Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis","volume":"12","author":"Tran","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0360","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.4161\/hv.25788","article-title":"Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis","volume":"9","author":"Cheng","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0365","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.4161\/hv.25787","article-title":"Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis","volume":"9","author":"Curti","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0370","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2015.00218","article-title":"Development of the Brazilian anti schistosomiasis vaccine based on the recombinant fatty acid binding protein Sm14 Plus GLA-SE adjuvant","volume":"6","author":"Tendler","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0375","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.vaccine.2013.12.057","article-title":"Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons","volume":"32","author":"Karmakar","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0380","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2008.04.080","article-title":"DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo","volume":"26","author":"Da\u2019dara","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0385","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrmicro2438","article-title":"Developing vaccines to combat hookworm infection and intestinal schistosomiasis","volume":"8","author":"Hotez","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0390","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0395","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00436-014-3879-8","article-title":"Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon","volume":"113","author":"Zhang","year":"2014","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0400","doi-asserted-by":"crossref","first-page":"e1004033","DOI":"10.1371\/journal.ppat.1004033","article-title":"An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas","volume":"10","author":"Gaze","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0405","doi-asserted-by":"crossref","first-page":"e1000840","DOI":"10.1371\/journal.ppat.1000840","article-title":"Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover","volume":"6","author":"Tran","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0410","series-title":"A phase I study of the safety, reactogenicity, and immunogenicity of Sm-TSP-2\/Alhydrogel\u00ae with or without GLA-AF for intestinal schistosomiasis in healthy adults","author":"ClinicalTrials.gov","year":"2015"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0415","series-title":"Study to evaluate the safety of the vaccine prepared sm14 against schistosomiasis","author":"ClinicalTrials.gov","year":"2013"},{"key":"10.1016\/j.vaccine.2016.03.079_bib0420","unstructured":"\u201cG-Finder\u201d. G-Finder. Policy cures."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:40:22Z","timestamp":1692258022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16300767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":41,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16300767"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.079","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726260766.793550916","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing a vaccine to prevent human schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}